HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Mark B Medina Selected Research

Paul Mark B Medina Research Topics

Disease

2Infections
11/2022 - 10/2022
2Premature Birth (Birth, Premature)
01/2022 - 01/2021
2Inflammation (Inflammations)
01/2022 - 01/2021
2Necrosis
01/2021 - 01/2021
1Fibrosis (Cirrhosis)
08/2022
1Schistosomiasis (Bilharziasis)
08/2022
1Schistosomiasis japonica
08/2022
1Gitelman Syndrome
01/2022
1Wounds and Injuries (Trauma)
12/2021
1Parkinson Disease (Parkinson's Disease)
12/2020
1Neurologic Manifestations (Neurological Manifestations)
11/2020
1COVID-19
11/2020

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2021
2CytokinesIBA
10/2022 - 01/2021
1N 30IBA
08/2022
1Biomarkers (Surrogate Marker)IBA
08/2022
1MicroRNAs (MicroRNA)IBA
08/2022
1MagnesiumIBA
01/2022
1SaltsIBA
01/2022
1CalciumIBA
01/2022
1Bacterial AntigensIBA
01/2022
1Indicators and Reagents (Reagents)IBA
12/2021
1EnzymesIBA
01/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2021
1ProgesteroneFDA LinkGeneric
01/2021
1p38 Mitogen-Activated Protein KinasesIBA
01/2021
1SmokeIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1GalactosidasesIBA
01/2021
1Gentian Violet (Violet, Crystal)FDA Link
01/2021
1ImmunosorbentsIBA
01/2021
1Levodopa (L Dopa)FDA LinkGeneric
12/2020
1Caffeine (No Doz)FDA LinkGeneric
12/2020
1Particulate MatterIBA
11/2020
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2020